HGE Health in the News
HGE Health Extends Its Telemedicine Technology Successes From One Disease To Another. From COPD to Idiopathic Pulmonary Fibrosis, Temple spin-off helps patients in trouble.
Mar 13, 2018 - A telemedicine-based disease management program proven to dramatically help chronic obstructive pulmonary disease (COPD) patients breathe easier is now giving patients with idiopathic pulmonary fibrosis (IPF) -- a deadlier form of pulmonary disease -- a fighting chance to do the same.
HGE Health, a Philadelphia-based healthcare technology company that works with pulmonary surgeons and physicians, is extending its HGE Care Advanced technology to help IPF patients in the U.S. and around the world.
Innovative HGE Health Telemedicine Technology Provides Safety Net to Vulnerable COPD Patients and Hospital Emergency Rooms Under Assault from Current Flu Season
Feb 5, 2018 - Advanced mobile healthcare technology and frequent patient-physician communications helping COPD patients remain healthier and much less anxious about this year’s flu. Meaning less ER, hospital and physician office visits…. and accompanying costs.
HGE Health's Telemedicine Technology Enables Nation's Leading Lung Transplant Hospital to Offer High Quality Care to Geographically Dispersed Lung Transplant Patients
Jan 1, 2018 - The product of more than a decade of research, HGE Health’s HGE Care Advance technology has helped patients remain stable and actively on transplant wait lists, aided pulmonary surgeons in better managing patients pre- and post-procedure, and enabled transplant facilities to increase their care to a more geographically diverse patient population.
Hospitals and doctors have identified digital tools that can assist patients in dealing with ailments such as diabetes, heart disease and lung disease. The early results are promising.
Interview with MedCity News' Neil Versel, the head of Temple University Health System's Temple Lung Center, Dr. Gerard Criner, discusses his and HGE Health's efforts in digital health and their program's success for patients with Chronic Obstructive Pulmonary Disease (COPD).
“We believe that timely, focused intervention was the primary reason for improvements in patient outcomes. Early intervention decreased the frequency and magnitude of subsequent exacerbation symptoms, decreased dyspnea, and improved peak flow and daily activity status,”